Moderator: Reginald Q. Knight, MD, MS
44. Correlation between NDI, PROMIS and SF-12 in cervical spinal surgery
Avani S. Vaishnav, MBBS1; Yahya A. Othman2; Steven J. McAnany, MD3; Sravisht Iyer, MD4; Todd J. Albert, MD1; Catherine Himo Gang, MPH1; Sheeraz A. Qureshi, MD, MBA5
1Hospital for Special Surgery, New York, NY, US; 2Weill Cornell Medicine, Qatar Foundation, Rayyan, Qatar; 3Hospital for Special Surgery, Stamford, CT, US; 4Rush University Medical Center, Chicago, IL, US; 5New York, NY, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
45. Trajectory of change in mJOA score within one year following surgery for degenerative cervical myelopathy
Inamullah Khan, MD1; Kristin R. Archer, PhD, DPT1; JP Wanner, MD2; Mohamad Bydon, MD3; Jacquelyn S. Pennings, PhD1; Ahilan Sivaganesan, MD1; Clinton J. Devin, MD1
1Vanderbilt University Medical Center, Nashville, TN, US; 2Nashville, TN, US; 3Mayo Clinic, Rochester, MN, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
46. Establishing maximal medical improvement following anterior cervical discectomy and fusion
Dil V. Patel, BS1; Joon S. Yoo, BA2; Benjamin Khechen, BA3; Anirudh K. Gowd, BS4; Arash Sayari, BS, MD1; Eric H. Lamoutte, BS3; Sailee S. Karmarkar, BS3; Joseph N. Liu, MD5; Kern Singh, MD1
1Rush University Medical Center, Chicago, IL, US; 2Chicago, IL, US; 3Midwest Orthopaedics at Rush, Chicago, IL, US; 4Virginia Tech Carilion School of Medicine, Roanoke, VA, US; 5Loma Linda, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
47. The effect of surgical decompression on spine and lower extremity range of motion during gait in patients with cervical spondylotic myelopathy
Ram Haddas, PhD, MSc, MEng1; Rajesh G. Arakal, MD2; Theodore A. Belanger, MD3; Thomas Kosztowski, MD2; Akwasi Boah, MD4; Yoheli Perez, PT, DPT1; Peter B. Derman, MD, MBA1
1Texas Back Institute, Plano, TX, US; 2Plano, TX, US; 3Texas Back Institute, Rockwall, TX, US; 4Texas Back Institute - Denton, Denton, TX, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
48. Identification of risk factors for readmission risk in patients undergoing ACDF: a predictive risk scale
Brianna L. Siracuse, MD1; Joseph Ippolito, MD2; John Shin, MD3; Colin B. Harris, MD3; Michael J. Vives, MD3
1Emory University School of Medicine-Department of Orthpaedics, Atlanta, GA, US; 2Newark, NJ, US; 3Rutgers-New Jersey Medical School, Newark, NJ, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
49. Increasing surgical invasiveness relative to frailty status in cervical deformity surgery: a risk benefit analysis
Peter G. Passias, MD1; Avery Brown, BS2; Bassel G. Diebo, MD3; Renaud Lafage, MSc4; Virginie Lafage, PhD4; Douglas C. Burton, MD5; Christopher P. Ames, MD6; Gregory M. Mundis Jr., MD7; Themistocles S. Protopsaltis, MD2; Robert A. Hart, MD8; Brian J. Neuman, MD9; Breton Line, BS10; Shay Bess, MD11; Alexandra Soroceanu, MD, MPH12; Christopher I. Shaffrey, MD13; Eric O. Klineberg, MD14; Justin S. Smith, MD, PhD15; Frank J. Schwab, MD4; International Spine Study Group16
1NY Spine Institute, NYU Langone Health, New York, NY, US; 2Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 3Department of Orthopaedic Surgery, SUNY Downstate Medical Center, Brooklyn, NY, US; 4Hospital for Special Surgery, New York, NY, US; 5University of Kansas Medical Center, Kansas City, KS, US; 6University of California, San Francisco, San Francisco, CA, US; 7Scripps Clinic Medical Group, Department of Orthopedics, La Jolla, CA, US; 8Swedish Neuroscience Institute, Seattle, WA, US; 9Baltimore, MD, US; 10Denver International Spine Center, Denver, CO, US; 11Denver, CO, US; 12University of Calgary, Calgary, Canada; 13University of Virginia, Charlottesville, VA, US; 14UC, Davis School of Medicine, Sacramento, CA, US; 15UVA Health System, Charlottesville, VA, US; 16Brighton, CO, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
50. Sagittal parameters poorly predict clinical outcomes following anterior cervical discectomy and fusion
Bryce Basques, MD, MHS1; Jannat M. Khan, MD2; Michael T. Nolte, MD3; Philip Louie, MD1; Kamran Movassaghi4; Jonathan Markowitz, BS5; Edward J. Goldberg, MD2; Howard S. An, MD3
1Rush University Medical Center, Chicago, IL, US; 2Midwest Orthopaedics at Rush University, Chicago, IL, US; 3Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, US; 4Glendale, CA, US; 5Rush Medical College, Chicago, IL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion